Rock Springs Capital Management LP Travere Therapeutics, Inc. Transaction History
Rock Springs Capital Management LP
- $2.94 Billion
- Q3 2024
A detailed history of Rock Springs Capital Management LP transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 4,684,476 shares of TVTX stock, worth $80.3 Million. This represents 2.23% of its overall portfolio holdings.
Number of Shares
4,684,476
Previous 4,482,265
4.51%
Holding current value
$80.3 Million
Previous $36.8 Million
77.87%
% of portfolio
2.23%
Previous 1.14%
Shares
12 transactions
Others Institutions Holding TVTX
# of Institutions
193Shares Held
84.6MCall Options Held
776KPut Options Held
900K-
Armistice Capital, LLC New York, NY7.65MShares$131 Million1.78% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$131 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.9MShares$118 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA4.34MShares$74.4 Million0.55% of portfolio
-
Macquarie Group LTD Australia, C34.27MShares$73.3 Million0.07% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.1B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...